Renaissance Technologies - DIPEXIUM PHARMACEUTICALS INC ownership

DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 20 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of DIPEXIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$612,000
+72.4%
42,200
+17.9%
0.00%0.0%
Q2 2016$355,000
+44.3%
35,800
+38.2%
0.00%
Q1 2016$246,000
+28.1%
25,900
+51.5%
0.00%
Q4 2015$192,000
-0.5%
17,100
+23.9%
0.00%
Q3 2015$193,00013,8000.00%
Other shareholders
DIPEXIUM PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 22,555$36,0000.02%
MIDDLETON & CO INC/MA 15,848$25,0000.01%
Tower Research Capital LLC (TRC) 13,480$21,0000.00%
FIRST NEW YORK SECURITIES LLC /NY 500$800,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 43,219$69,0000.00%
Raymond James Financial Services Advisors, Inc. 10,200$16,0000.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
BlackRock Investment Management, LLC 956$2,0000.00%
GOLDMAN SACHS GROUP INC 24,377$39,0000.00%
MORGAN STANLEY 8,054$12,0000.00%
View complete list of DIPEXIUM PHARMACEUTICALS INC shareholders